Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… FDA Guidance In June 2018, the United States Food and Drug Administration (US FDA) released an important guidance … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; … Executive Committee (FEC) provided an overview of upcoming changes to the AMCP guidelines. It is expected that these …
… have been evaluated through various health technology assessment (HTA) frameworks around the world. Because assessment by HTA organizations is still evolving, there is a lack of harmonization among various agencies on processes and methods. Information …
… Data Analytics and Design Strategy RTI Health Solutions Drug manufacturers are preparing to navigate joint clinical assessment (JCA) in several ways. On one hand, companies are … in advance and nimbly adjust to the final scope and label changes. Having a range of strategy, planning, evidence …
… with our clients on projects to research respiratory disease, respiratory treatment, and complications and … illnesses. Benefit-risk preference studies Consulting on drug development and clinical trial design Database analyses using cross-sectional and longitudinal data sources …
… Related Services Health Preference Assessment Staff Members Caroline Vass …
… our clients on projects to research cardiovascular (CV) disease, CV treatment, and complications and comorbidities of … studies Cost-utility analysis Database analyses using cross-sectional and longitudinal data sources Decision-analytic models Disease prevalence Drug utilization studies Economic analyses of clinical trial …
… in observational studies) is launched Ensuring patients can trust the safety and effectiveness of their … Devices (AEMPS), Spain Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), Spain University of …
… At a time when real-world data is gaining visibility among non-pharmacoepidemiologists, I see ISPE promoting sound … Their focus includes such areas as pharmacovigilance, drug utilization research, comparative effectiveness review, … forum to the views of all parties with interests in drug development, drug delivery, drug use, drug costs, and …
… journey and assess patient-reported outcomes of women using their treatment for advanced or metastatic breast … was little information on the day-to-day impact of the disease and its treatment on health-related quality of life. … noninterventional, multicenter longitudinal study of US patients that included patient chart abstractions and patient …
… authorization process in the EU. It is critical that drug and device developers become informed on the latest … strategies and preparatory activities for different assessment scenarios. Our experts can help you with: PICO … consulting capacity support and staff extenders JCA impact assessment full portfolio therapeutic area single asset …